2-(2,6-Dimethylmorpholino)-2-oxoethyl 2,6-dichlorobenzoate

Catalog No. :
ACDUFX175
CAS No. :
474892-43-8
Molecular Formula :
C15H17Cl2NO4
Molecular Weight :
346.21

IUPAC Name:2-(2,6-dimethylmorpholino)-2-oxoethyl 2,6-dichlorobenzoate

2-(2,6-Dimethylmorpholino)-2-oxoethyl 2,6-dichlorobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$204.00Login to see priceInquiryInquiry
250mg98%$347.00Login to see priceInquiryInquiry
1g98%$935.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2,6-Dimethylmorpholino)-2-oxoethyl 2,6-dichlorobenzoate
IUPAC Name2-(2,6-dimethylmorpholino)-2-oxoethyl 2,6-dichlorobenzoate
Molecular FormulaC15H17Cl2NO4
Molecular Weight346.21
SMILESCC1CN(C(COC(C2=C(Cl)C=CC=C2Cl)=O)=O)CC(C)O1
InChI KeyUGTPXQXEBKMHJY-UHFFFAOYSA-N
SynonymWAY-351892;2-(2,6-Dimethylmorpholino)-2-oxoethyl 2,6-dichlorobenzoate;Benzoic acid, 2,6-dichloro-, 2-(2,6-dimethyl-4-morpholinyl)-2-oxoethyl ester
CAS No.474892-43-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACDUFX175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICYP521 route compound structure diagram
    ACICYP52110007-84-8 In Stock
  4. Then
  5. ACDUFX175 route product structure diagram
    ACDUFX175474892-43-8
Inquiry

2. ACDUFX175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTPO970 route compound structure diagram
    ACBTPO97080567-00-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDUFX175 route product structure diagram
    ACDUFX175474892-43-8
Inquiry

Comments (0)